e-learning
resources
Munich 2006
Wednesday 06.09.2006
Inflammation markers in community-acquired pneumonia
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
D-dimer elevation is associated with severity of community-acquired pneumonia according to CURB-65 and PSI
D. Snijders, P. C. Bartels, C. S. de Graaff, W. G. Boersma (Alkmaar, Netherlands)
Source:
Annual Congress 2006 - Inflammation markers in community-acquired pneumonia
Session:
Inflammation markers in community-acquired pneumonia
Session type:
Oral Presentation
Number:
4655
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Snijders, P. C. Bartels, C. S. de Graaff, W. G. Boersma (Alkmaar, Netherlands). D-dimer elevation is associated with severity of community-acquired pneumonia according to CURB-65 and PSI. Eur Respir J 2006; 28: Suppl. 50, 4655
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Pulmonary sarcoidosis
Related content which might interest you:
Systemic cytokine levels in community-acquired pneumonia and their association with disease severity
Source: Eur Respir J 2002; 20: 990-995
Year: 2002
Severity assessment of healthcare-associated pneumonia and pneumonia in immunosuppression
Source: Eur Respir J 2012; 40: 1201-1210
Year: 2012
Biomarkers and severity in community-acquired pneumonia (CAP)
Source: Annual Congress 2012 - Prognostic indices in respiratory infections
Year: 2012
Value of hypoalbuminemia as a sign of severity of community-acquired pneumonia
Source: Annual Congress 2007 - Community-acquired pneumonia: from aetiology to complication
Year: 2007
Is severity index enough to assess hospital admission of community-acquired pneumonia (CAP) patients?
Source: Annual Congress 2006 - Evaluation of risk factors in community-acquired pneumonia
Year: 2006
Incidence of severe sepsis as a cause of clinical failure in patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2007; 30: Suppl. 51, 42s
Year: 2007
Predicting severe sepsis in community-acquired pneumonia using CURB65 and PSI scores
Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections
Year: 2008
Clinical pulmonary infection score (CPIS) and inflammatory response in patients with new pulmonary infiltrates and suspected ventilator acquired pneumonia (VAP)
Source: Annual Congress 2005 - Diagnosis and prognosis of ventilator associated pneumonia: the clinical track
Year: 2005
COPD is associated with increased mortality in patients with community-acquired pneumonia
Source: Eur Respir J 2006; 28: 346-351
Year: 2006
Management-based risk prediction in community-acquired pneumonia by scores and biomarkers
Source: Eur Respir J 2013; 41: 974-984
Year: 2013
Physicians should not use the pneumonia severity index (PSI) or CRB-65 in deciding the need for hospitalization in cancer patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2007; 30: Suppl. 51, 41s
Year: 2007
Community-acquired pneumonia (CAP): evaluation of severity criteria for hospitalization
Source: Eur Respir J 2003; 22: Suppl. 45, 335s
Year: 2003
Copeptin application in severe community-acquired pneumonia (SCAP) severity assessment and outcomes
Source: Annual Congress 2012 - Respiratory infections: a clinical point of view
Year: 2012
Severity and outcomes of hospitalised community-acquired pneumonia in COPD patients
Source: Eur Respir J 2012; 39: 855-861
Year: 2012
Sepsis severity predicts outcome in community-acquired pneumococcal pneumonia
Source: Eur Respir J 2007; 30: 517-524
Year: 2007
Inflammatory biomarkers in predicting ICU admission of severe community-acquired pneumonia (CAP)
Source: Annual Congress 2011 - Pulmonary infections and sepsis
Year: 2011
C-reactive protein as severity biomarker in patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2005; 26: Suppl. 49, 545s
Year: 2005
Validation of pneumonia severity models for healthcare-associated pneumonia (HCAP)
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010
Prognostic value of procalcitonin in community-acquired pneumonia
Source: Eur Respir J 2011; 37: 384
Year: 2011
Serum KL-6 elevation related with severity in patients with pneumocystis pneumonia
Source: Annual Congress 2011 - Infection in the immunocompromised host: infrequent aetiologies
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept